Alberta, Canada, Jan. 21, 2021 /CNW/ - CanadaBis Capital Inc.
("CanadaBis" or "the Company") with its subsidiary Stigma Grow, is
a vertically integrated Canadian cannabis company focused on
capitalizing growth and diversification opportunities. The
Company is proud to report certain operational updates.
"Our goal remains steadfast: to be a profitable cash flowing
company. Thanks to our newly secured 2.0 license and recent
commercial activity we are excited to announce that we are
achieving this goal sooner than expected. With our focus on being a
low cost-high quality producer and having all services in house, we
can expect to continue to see profitable margins from all of our
offerings even as historical pricing drops and the concentrates
market continues to grow." says CEO Travis
McIntyre.
The Company is thrilled to announce that is has signed Contracts
with British Columbia,
Alberta, Saskatchewan and Manitoba, and are currently working with
Ontario to finalize an agreement
with their wholesale department to supply products for both their
medical and recreational clients. The result is that the
Company's branded products (Black NGL, White NGL, Dab Bods, and
Chapter 1) which have been positioned to compete with legacy market
pricing and potency, can begin to attract consumers who, to-date,
have been unmoved by the pricing and product selection of the legal
market. The Company believes this approach will lead to long-term
stable margins within an underserved niche — providing a great
platform to build real, long-term revenues with impressive
bottom-line performance.
The Company has successfully developed several diversified SKUs
under a variety of brands positioned to capture and increase market
share across Canada. One of these
products is our first-to-market, live-resin vape cartridge. In
addition to being the first of its kind in Canada's legal market, it enters a category of
cannabis that represents approximately 15% of total cannabis
product sales in Canada1.
We believe that this is the only product on the market boasting
NO additives, NO added terpenes and NO Glycol or MCT cutting
agents. In addition to containing up to 98% cannabinoids, our
hydrocarbon system preserves the original terpene profile for an
unmatched, full-plant experience.
Another operational highlight is the release of our Chapter 1:
RSO Capsules. For those who are not familiar, RSO is a potent,
full-plant extract commonly used by medical patients and those
seeking the ultimate potency in their cannabis products.
This product, while being a staple in the legacy and medical
markets, has not been widely offered in the legal Market and we
thought it was about time to introduce this product to a wider
consumer base.
1 Cannabis market data: Overview.
https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/market.html
About Stigma Grow
Stigma Grow is a cutting-edge cannabis cultivation and
extraction company positioned advantageously to meet the unmet
market demands and stigmas within the legal cannabis industry head
on, with products designed to disturb the status quo and
dramatically shift the conversation surrounding Canada's legal cannabis industry.
About CanadaBis Capital Inc.
CanadaBis Capital Inc.
(TSXV: CANB) is a vertically integrated Canadian cannabis company
focused on achieving large-scale growth in the fast-emerging global
cannabis market. By targeting organic growth opportunities
alongside the right-fit partners, we remain focused on finding and
capitalizing on chances to grow, diversify and continue to lead our
industry.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION:
This news release includes certain "forward-looking
statements" under applicable Canadian securities legislation.
Forward-looking statements include, but are not limited to,
statements with respect to our business and operations; timing of
the Company's profitability; the demand and sales volumes of the
Company's products, and our general business plans. Forward-looking
statements are necessarily based upon a number of assumptions
including: the ability of the Company's products to compete with
the pricing and product availability on the black-market; the
market demand for the Company's products; and assumptions
concerning the Company's competitive advantages. These
assumptions, while considered reasonable, are subject to
known and unknown risks, uncertainties, and other factors which may
cause actual results and future events to differ materially from
those expressed or implied by such forward-looking statements. Such
factors include but are not limited to: compliance with extensive
government regulation, the general business, economic, competitive,
political and social uncertainties; ability to sustain or create
demand for a product; requirement for further capital; delay or
failure to receive board, shareholder or regulatory approvals; the
results of operations and such other matters as set out in the
Company's continuous disclosure on SEDAR at www.sedar.com. There
can be no assurance that such statements will prove to be accurate,
as actual results and future events could differ materially from
those anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
information prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated,
believed, estimated or expected. Although the Company has attempted
to identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended.
Company does not intend, and does not assume any obligation, to
update this forward-looking information except as otherwise
required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE CanadaBis Capital Inc.